Consistent with the data from mice samples, the expression of CCL2 and CCR2 was higher in the human hepatic metastases than primary CRC samples validated by immunohistochemistry and Q-PCR (Fig. 5F, G). The gene discussed is CCL2; the disease is colorectal carcinoma.